Home › Funds › Baird Mid Cap Growth Fund
Fund family: Baird · Filed by BAIRD FUNDS INC (CIK 1282693) · SEC series S000000759
Share classes and tickers: BMDIX (C000002174), BMDSX (C000002175)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 521 with, 10 against, 8 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 7 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other Baird funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most Baird funds on all 16 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 97.8% of this fund’s 539 such votes could be given a sector; the other 12 (2.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 207 | 4 | 1.9% |
| Health Care | 104 | 2 | 1.9% |
| Technology | 102 | 3 | 2.9% |
| Industrials | 41 | 0 | 0.0% |
| Finance | 30 | 1 | 3.3% |
| Miscellaneous | 26 | 0 | 0.0% |
| Energy | 11 | 0 | 0.0% |
| Basic Materials | 6 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 410 | 1 |
| Audit-related | 51 | 0 |
| Say-on-Pay | 50 | 0 |
| Corporate Governance | 14 | 6 |
| Compensation | 8 | 0 |
| Capital Structure | 3 | 0 |
| Shareholder Rights and Defenses | 3 | 1 |
| Environment or Climate | 1 | 1 |
| Human Rights or Human Capital/workforce | 1 | 0 |
| Investment Company Matters | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| CASEY'S GENERAL STORES, INC. | September 3, 2025 | $45M | 15 | 1 |
| WEST PHARMACEUTICAL SERVICES, INC. | May 4, 2026 | $38M | 14 | 1 |
| FERGUSON ENTERPRISES INC. | December 3, 2025 | $32M | 13 | 0 |
| HILTON WORLDWIDE HOLDINGS INC. | May 14, 2026 | $30M | 13 | 0 |
| FASTENAL COMPANY | April 23, 2026 | $28M | 16 | 0 |
| ILLUMINA, INC. | May 21, 2026 | $27M | 11 | 0 |
| RESMED INC. | November 19, 2025 | $26M | 15 | 0 |
| VICTORIA'S SECRET & CO. | June 11, 2026 | $24M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| September 3, 2025 | CASEY'S GENERAL STORES, INC. | Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposal | Against | For |
| May 4, 2026 | WEST PHARMACEUTICAL SERVICES, INC. | Shareholder proposal regarding an independent Board Chair policy. Shareholder proposal | For | Against |
| May 12, 2026 | IDEXX LABORATORIES, INC. | Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six). Shareholder proposal | For | Against |
| May 5, 2026 | TYLER TECHNOLOGIES, INC. | Shareholder Proposal Regarding Political Spending. Shareholder proposal | Against | For |
| May 7, 2026 | EQUIFAX INC. | Shareholder proposal to lower the ownership threshold to call a special meeting of shareholders to 10%. Shareholder proposal | For | Against |
| June 18, 2026 | DELTA AIR LINES, INC. | A shareholder proposal requesting the ability for shareholders to act by written consent. Shareholder proposal | For | Against |
| June 18, 2026 | DELTA AIR LINES, INC. | shareholder proposal requesting the adoption of cumulative voting for the election of directors. Shareholder proposal | Against | For |
| May 19, 2026 | VERISK ANALYTICS, INC. | Shareholder Proposal - Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
| June 15, 2026 | DATADOG, INC. | The stockholder proposal, if properly presented at the Annual Meeting, requesting the adoption of a simple majority voting provision. Shareholder proposal | For | Against |
| May 21, 2026 | CDW CORPORATION | To consider and act upon the stockholder proposal, if properly presented at the meeting, regarding independent Board chair requirements. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
543 ballot items at 51 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Baird Mid Cap Growth Fund (BMDIX) voted at 51 shareholder meetings of 49 companies, on 543 ballot items in all. Where management made a recommendation, the fund followed it on 96.7% of the items and voted against it 10 times. Its most frequent area of disagreement was corporate governance (6 of its votes against management). It voted on 11 shareholder proposals. It voted the same way as most Baird funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.